Insider Transactions in Q2 2021 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,167
-11.1%
|
$170,847
$41.74 P/Share
|
|
Jun 30
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,167
+7.23%
|
$62,505
$15.35 P/Share
|
|
Jun 18
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
1,301
-12.44%
|
$50,739
$39.8 P/Share
|
|
Jun 18
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
1,301
+11.06%
|
$28,622
$22.55 P/Share
|
|
Jun 17
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
651
-6.64%
|
$26,040
$40.0 P/Share
|
|
Jun 17
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
651
+6.22%
|
$14,322
$22.55 P/Share
|
|
Jun 17
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
4,000
-72.67%
|
$160,000
$40.0 P/Share
|
|
Jun 17
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+42.09%
|
$28,000
$7.8 P/Share
|
|
Jun 17
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,583
-20.06%
|
$583,320
$40.0 P/Share
|
|
Jun 17
2021
|
R Mark Adams Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+16.71%
|
$408,324
$28.1 P/Share
|
|
Jun 17
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,166
-21.7%
|
$166,640
$40.0 P/Share
|
|
Jun 17
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+7.23%
|
$62,490
$15.35 P/Share
|
|
Jun 17
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,255
-0.15%
|
$204,945
$39.15 P/Share
|
|
Jun 16
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
4,745
-0.27%
|
$180,310
$38.13 P/Share
|
|
Jun 15
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
20,000
-0.57%
|
$760,000
$38.73 P/Share
|
|
Jun 14
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,914
-13.3%
|
$338,732
$38.77 P/Share
|
|
Jun 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
2,500
-62.44%
|
$95,000
$38.56 P/Share
|
|
Jun 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+38.44%
|
$17,500
$7.8 P/Share
|
|
Jun 11
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-5.32%
|
$148,010
$38.41 P/Share
|
|
Jun 11
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jun 10
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$144,115
$37.32 P/Share
|
|
Jun 10
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jun 09
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$140,220
$36.21 P/Share
|
|
Jun 09
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jun 09
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$350,000
$35.6 P/Share
|
|
Jun 09
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
Jun 08
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-16.74%
|
$370,000
$37.38 P/Share
|
|
Jun 08
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
May 18
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
651
-6.64%
|
$22,785
$35.0 P/Share
|
|
May 18
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
651
+6.22%
|
$14,322
$22.55 P/Share
|
|
May 18
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
2,500
-62.44%
|
$87,500
$35.0 P/Share
|
|
May 18
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+38.44%
|
$17,500
$7.8 P/Share
|
|
May 17
2021
|
Henning Thorsen SVP, Commercial Operations |
BUY
Grant, award, or other acquisition
|
Direct |
29,061
+50.0%
|
-
|
|
May 14
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.85%
|
$66,000
$33.8 P/Share
|
|
May 14
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+8.13%
|
$14,000
$7.8 P/Share
|
|
May 12
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$320,000
$32.63 P/Share
|
|
May 12
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
May 11
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-16.97%
|
$310,000
$31.33 P/Share
|
|
May 11
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
May 06
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$136,325
$35.95 P/Share
|
|
May 06
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
May 05
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,195
-4.4%
|
$111,825
$35.43 P/Share
|
|
May 05
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
May 04
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$140,220
$36.4 P/Share
|
|
May 04
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Apr 30
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,166
-21.7%
|
$170,806
$41.93 P/Share
|
|
Apr 30
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+7.23%
|
$62,490
$15.35 P/Share
|
|
Apr 22
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,790
-5.18%
|
$334,970
$43.22 P/Share
|
|
Apr 22
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,790
+9.17%
|
$46,740
$6.32 P/Share
|
|
Apr 21
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,790
-3.45%
|
$311,600
$40.94 P/Share
|